Anti-Human IGHE Recombinant Antibody(Tanezumab)
-
产品编号
YR1147
-
别名
科研级 Tanezumab ( 他尼组单抗 ), Anti-IGHE Recombinant Antibody, Research Grade Tanezumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1147 |
| Alias | 科研级 Tanezumab ( 他尼组单抗 ), Anti-IGHE Recombinant Antibody, Research Grade Tanezumab |
| Size | 1mg, 5mg |
| Molecular Name | Tanezumab |
| CAS Number | 880266-57-9 |
| Target | IGHE[Homo sapiens] |
| Host | Mouse |
| Antibody Isotype | IgG1 |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Tanezumab (INN, codenamed RN624) is a monoclonal antibody against nerve growth factor as a treatment for pain. Tanezumab was discovered and developed by Rinat Neuroscience and was acquired by Pfizer in 2006. |
| Application | ELISA, FuncS, Inhib |
| Remarks | This product is for research use only. |
0